Mesoblast Expands Partnership With JCR for Treatment of Wound Healing in Epidermolysis Bullosa
Mesoblast Limited announced it has expanded its partnership with JCR Pharmaceuticals Co. Ltd. in Japan for wound healing in patients with Epidermolysis Bullosa (EB).
JCR has received…
Read More...
Read More...
